FIELD: catalyst preparation methods.
SUBSTANCE: invention relates to alumina-supported catalyst preparation method and employment thereof in reactions of nucleophilic substitution of aromatic halides containing electron-accepting group. In particular, alumina support impregnated with alkali selected from alkali metal hydroxides is prepared by treating alkali metal hydroxide aqueous solution with aluminum oxide in organic solvent followed by drying thus obtained catalyst mixture at temperature not lower than 150°C. Catalyst is, in particular, used to introduce electron-accepting protective groups into organic compounds comprising at least one of -OH, -SH, and -NH, as well as in reaction of substituting amino, thio, or ether group for halogen in a haloarene and in preparation of 2-puperidinobenzonitrile.
EFFECT: simplified preparation of catalyst and regeneration of spent catalyst, and avoided involvement of dangerous reactants.
11 cl, 20 ex
Title | Year | Author | Number |
---|---|---|---|
OXAZOLO- AND THIAZOLO-[4,5-C]-QUINOLINE-4-AMINES, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR STIMULATING BIOSYNTHESIS OF CYTOKININS (CYTOKINES) | 1999 |
|
RU2244717C2 |
SERINE PROTEASE INHIBITOR AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1999 |
|
RU2232760C2 |
CATALYSTS FOR OBTAINING BIMODAL RESIN BASED ON COMBINED ORGANIC CHROME COMPOUND AND METALLOCENE | 2004 |
|
RU2355709C2 |
METHOD FOR SYNTHESIS OF ANTICANCER COMPOUND AND INTERMEDIATE COMPOUNDS THEREOF | 2021 |
|
RU2837452C1 |
ANTIMICROBIAL PHENYLOXAZOLIDINONES | 1995 |
|
RU2134692C1 |
HYDROXYETHYLAMINOSULFONEAMIDES, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION RETROVIRAL PROTEASES, METHOD OF TREATMENT OF RETROVIRAL INFECTIONS, METHOD OF TREATMENT OF AIDS | 1993 |
|
RU2173680C2 |
DERIVATIVES OF QUINOLINE XANTHINE AND 8-ISOQUINOLINE XANTHINE AS INHIBITORS OF PHOSPHODIESTERASE PDE-5 | 2001 |
|
RU2269529C2 |
DUAL METALLOCENE CATALYST FOR PRODUCING FILM RESINS WITH GOOD MACHINE DIRECTION (MD) ELMENDORF TEAR STRENGTH | 2005 |
|
RU2382793C2 |
IONIC LIQUID | 2014 |
|
RU2654697C2 |
TRIPEPTIDE COMPOUND, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2015 |
|
RU2685709C2 |
Authors
Dates
2006-05-10—Published
2001-09-20—Filed